| Lack of mutations in LMNA, its promoter region, and the cellular retinoic acid binding protein II (CRABP II) in HIV associated lipodystrophy. | |
| | |
MedLine Citation:
|
PMID: 12844477 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Familial partial lipodystrophy (FPL) and lipodystrophy observed in HIV-1 infected patients receiving highly active antiretroviral therapy (HAART) share multiple clinical and metabolic features. Recently, missense mutations of LMNA encoding lamin A/C have been described in FPL providing evidence for a pivotal role of lamin A/C in the regulation of adipocytes. Moreover, the cellular retinoic acid binding protein (CRABP) has been suggested to be involved in HAART associated lipodystrophy. In this study, we excluded mutations within the complete coding region and the promoter of LMNA and the CRABP II gene in HIV-1 infected patients with lipodystrophy and also any correlation of the nucleotide polymorphism at codon 566 in exon 10 of LMNA with metabolic abnormalities. Protease inhibitors including indinavir have been shown to reduce adipocyte cell differentiation and increase apoptosis of adipocytes in vitro. Indinavir leads to altered retinoic acid signaling most likely by an activation of the RAR/RXR heterodimer, perhaps by displacing all-trans-retinoic acid from CRABP. Since LMNA is regulated by a retinoic acid responsive element (L-RARE) in the promoter region, we propose that indinavir impairs retinoic acid homeostasis and/or interact via the L-RARE within the LMNA promoter. This results in altered LMNA expression and subsequent impaired adipocyte differentiation, lipodystrophic body habitus, and metabolic disturbances in HIV infected patients receiving HAART. |
| | |
Authors:
|
G M N Behrens; J Genschel; R E Schmidt; H H-J Schmidt |
Related Documents
:
|
20947997 - Disseminate and persistent infundibulo-folliculitis. 8646757 - Regulation of differentiation and keratin 10 expression by all-trans retinoic acid duri... 21302317 - Effect of irradiation, active and modified atmosphere packaging, container oxygen barri... 11911407 - Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic stu... 907427 - Reversion by fe(iii) of the inhibition by hydroxamic acids of the cyanide-insensitive r... 17123457 - Electrospun poly(vinylidene fluoride)/poly(aminophenylboronic acid) composite nanofibro... |
Publication Detail:
|
Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: European journal of medical research Volume: 8 ISSN: 0949-2321 ISO Abbreviation: Eur. J. Med. Res. Publication Date: 2003 May |
Date Detail:
|
Created Date: 2003-07-07 Completed Date: 2004-02-03 Revised Date: 2008-11-21 |
Medline Journal Info:
|
Nlm Unique ID: 9517857 Medline TA: Eur J Med Res Country: Germany |
Other Details:
|
Languages: eng Pagination: 221-5 Citation Subset: IM |
Affiliation:
|
Immunology Division, The Walter and Eliza Hall Institute of Medical Research, IG Royal Parade, Parkville 3050, Victoria, Australia. behrens@wehi.edu.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Amino Acid Sequence Antiretroviral Therapy, Highly Active / adverse effects HIV Infections / complications*, drug therapy HIV Protease / genetics Humans Laminin / genetics* Lipodystrophy / complications, genetics*, pathology Models, Biological Mutation Polymorphism, Single Nucleotide Promoter Regions, Genetic* Receptors, Retinoic Acid / chemistry, genetics*, metabolism Sequence Homology, Amino Acid |
| Chemical | |
Reg. No./Substance:
|
0/Laminin; 0/Receptors, Retinoic Acid; 0/retinoic acid binding protein II, cellular; 151186-83-3/laminin A; EC 3.4.23.-/HIV Protease |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The dependency of expiratory airway collapse on pump system and flow rate in liquid ventilated rabbi...
Next Document: Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvem...